Basking Biosciences
Latest round
- Series B
Last raised
- Jan 2024
Total raised
- $60M
Investors
- 10
About Basking Biosciences
, operates as a healthcare specialist that develops a thrombolytic therapy for acute ischemic stroke. The company was co-founded by Dr. Bruce Sullenger of Duke University and Dr. Shahid Nimjee of The Ohio State University founded the company. Mr. Richard Shea is the CEO of the company. The company developed DTRI-025 in Q4 2020. The company focuses on exploiting the properties of RNA biochemistry to develop aptamers with high affinity and specificity against proteins involved in coagulation and hemostasis. The company develops the first reversible thrombolytic therapy for Acute Ischemic Stroke (AIS). The solution of company includes DTRI-031 and it can inhibits von Willebrand Factor (vWF). And its solution DTRI-025 is continuing IND-enabling development.
Who invested in Basking Biosciences
10 investors across 2 rounds
See all investors in Basking Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Basking Biosciences
Who invested in Basking Biosciences?
Basking Biosciences has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Basking Biosciences raised?
Basking Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Basking Biosciences last raise money?
Basking Biosciences's most recent round on record is a Series B, in Jan 2024.
What does Basking Biosciences do?
, operates as a healthcare specialist that develops a thrombolytic therapy for acute ischemic stroke.
Where is Basking Biosciences headquartered?
Basking Biosciences is headquartered in US.
Which VCs invest in companies like Basking Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Basking Biosciences's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like Basking Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.